Delivery Order SPE2DB25D9348-SPE2DB25FNMWL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant product. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is headquartered. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with a period of performance through April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB20D9354 with the DLA, which has a ceiling value of up...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Mirena 52 mg contraceptive systems. The award was issued under a firm fixed-price contract with an ultimate completion date of September 4, 2025. This delivery order represents a discrete procurement from DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, which is valued at approximately $500 million and valid through November...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,880.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Mirena 52 mg intrauterine systems. This delivery order is placed against DMS Pharmaceutical Group's existing $4,999,999 indefinite delivery contract with DLA for pharmaceutical products, which supports the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract worth $7,104.00 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. This order is for the delivery of Mirena 52 mg systems, a contraceptive implant, with a completion date of March 5, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMWLDelivery Order
The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a hormonal contraceptive implant device. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. This delivery order does not include a set-aside designation, and the place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters as a woman-owned small business. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has supplied a broad portfolio of medications and medical products to Defense Logistics Agency and Department of Defense healthcare facilities since at least 2001. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. Under its SPE2DB indefinite delivery vehicle with DLA, the company regularly fulfills delivery orders for pharmaceutical products ranging from contraceptive devices to oncology treatments and specialty medications, positioning it as a key supplier within the federal pharmaceutical supply chain supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/2/25 |